Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)

NCT04900428 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
179
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated at interim analysis due to drops not working on new variants

Conditions

Interventions

Sponsor

Sorrento Therapeutics, Inc.